The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer.
Makvandi M, Tilahun ED, Lieberman BP, Anderson RC, Zeng C, Xu K, Hou C, McDonald ES, Pryma DA, Mach RH.
Makvandi M, et al. Among authors: mcdonald es.
Biochem Biophys Res Commun. 2015 Nov 27;467(4):1070-5. doi: 10.1016/j.bbrc.2015.09.157. Epub 2015 Oct 9.
Biochem Biophys Res Commun. 2015.
PMID: 26453012
Free PMC article.